Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months
Robert N. Piana, MD, FACC*,
Waqar H. Ahmed, MD, MS, FACC*,
Bernard Chaitman, MD, FACC
,
Peter Ganz, MD, FACC*,
Scott Kinlay, MBBS*,
John Strony, MD, FACC
,
Burt Adelman, MD
,
John A. Bittl, MD, FACC|| on behalf of the Hirulog Angioplasty Study Investigators
* Department of Medicine, Brigham & Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA
Department of Medicine, St. Louis University, St. Louis, Missouri, USA
Department of Medicine, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA
Biogen Inc., Cambridge, Massachusetts, USA
|| Ocala Heart Institute, Ocala, Florida, USA

View larger version (17K):
[in a new window]
|
Figure 1 Flow diagram of patients in-hospital course in the Hirulog Angioplasty Study. AVC = abrupt vessel closure. *"Uncomplicated" abrupt vessel closure indicates that the abrupt closure event did not result in a major ischemic complication (death, myocardial infarction or emergent coronary artery bypass graft surgery). "Complicated" abrupt vessel closure indicates that the abrupt closure event did result in a major ischemic complication (death, myocardial infarction or emergent coronary artery bypass graft surgery).
|
|
Copyright © 1999 by the American College of Cardiology Foundation.